secwatch.observer — SEC 8-K summary
======================================

Issuer:     biote Corp. (BTMD)
CIK:        0001819253
Form:       8-K
Filed at:   2026-03-11T23:59:59+00:00
Accession:  0001193125-26-102129
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biote Q4 revenue $46.4M; net income $2.6M; anticipates procedure growth H2 2026
-------------------------------------------------------------------------------

- Q4 2025 revenue $46.4M, gross margin 68.0%; net income $2.6M ($0.06 diluted EPS), down from $3.5M ($0.10) in Q4 2024.
- Full year 2025 revenue $192.2M; net income $31.6M ($0.74 diluted EPS), versus $0.05M ($0.09) in 2024.
- Adjusted EBITDA Q4 $11.7M (25.2% margin); full year adjusted EBITDA $53.5M (27.8% margin).
- CEO Bret Christensen anticipates return to procedure revenue growth in second half of 2026.
- Company rebuilding commercial sales coverage; commercial transition impacted 2025 results as expected.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819253/000119312526102129/0001193125-26-102129-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819253/000119312526102129/btmd-20260311.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-102129

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer